Selected Quarterly Financial Information - Summary of Company's Selected Quarterly Financial Information (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Net patient service revenue | $ 567,387 | $ 554,730 | $ 529,180 | $ 502,715 | $ 471,332 | $ 473,134 | $ 449,530 | $ 422,616 | $ 2,154,012 | $ 1,816,612 | $ 1,588,248 |
Practice salaries and benefits | 353,316 | 346,879 | 331,922 | 329,201 | 290,671 | 292,030 | 275,951 | 272,261 | 1,361,318 | 1,130,913 | 970,396 |
Practice supplies and other operating expenses | 24,027 | 19,445 | 19,416 | 19,500 | 19,276 | 17,606 | 17,956 | 16,985 | 82,388 | 71,823 | 66,815 |
General and administrative expenses | 55,636 | 54,654 | 54,601 | 53,318 | 50,271 | 48,200 | 48,200 | 46,869 | 218,209 | 193,540 | 170,356 |
Depreciation and amortization | 10,491 | 10,461 | 9,870 | 9,144 | 8,091 | 7,925 | 7,687 | 7,113 | 39,966 | 30,816 | 25,292 |
Total operating expenses | 443,470 | 431,439 | 415,809 | 411,163 | 368,309 | 365,761 | 349,794 | 343,228 | 1,701,881 | 1,427,092 | 1,232,859 |
Income from operations | 123,917 | 123,291 | 113,371 | 91,552 | 103,023 | 107,373 | 99,736 | 79,388 | 452,131 | 389,520 | 355,389 |
Investment income | 526 | 372 | 396 | 402 | 681 | 422 | 365 | 428 | 1,696 | 1,896 | 1,495 |
Interest expense | (1,046) | (1,507) | (1,673) | (1,189) | (1,219) | (624) | (848) | (554) | (5,415) | (3,245) | (3,639) |
Income before income taxes | 123,397 | 122,156 | 112,094 | 90,765 | 102,485 | 107,171 | 99,253 | 79,262 | 448,412 | 388,171 | 353,245 |
Income tax provision | 44,423 | 45,198 | 42,876 | 35,398 | 36,382 | 41,261 | 38,709 | 30,912 | 167,895 | 147,264 | 135,248 |
Net income | $ 78,974 | $ 76,958 | $ 69,218 | $ 55,367 | $ 66,103 | $ 65,910 | $ 60,544 | $ 48,350 | $ 280,517 | $ 240,907 | $ 217,997 |
Net income, Basic | $ 0.79 | $ 0.77 | $ 0.70 | $ 0.56 | $ 0.67 | $ 0.67 | $ 0.62 | $ 0.50 | $ 2.83 | $ 2.47 | $ 2.28 |
Net income, Diluted | $ 0.78 | $ 0.76 | $ 0.68 | $ 0.55 | $ 0.66 | $ 0.66 | $ 0.61 | $ 0.49 | $ 2.78 | $ 2.42 | $ 2.23 |
Weighted average shares, Basic | 99,469 | 99,506 | 99,116 | 98,618 | 98,226 | 97,876 | 97,086 | 96,538 | 99,112 | 97,386 | 95,412 |
Weighted average shares, Diluted | 101,080 | 101,178 | 101,098 | 100,784 | 100,212 | 99,618 | 99,090 | 98,798 | 100,969 | 99,382 | 97,592 |
X | ||||||||||
- Definition
The aggregate amount of supplies and other operating expenses directly attributable to the physician practices. No definition available.
|
X | ||||||||||
- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|